In a major development, Gilead Sciences Inc announced on Friday that an analysis showed that their antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, says an article published in Reuters
However, the company has cautioned against its use saying that rigorous clinical trials were needed to confirm the benefit.
Statistically Insignificant ResultsRemdesivir has been at the forefront of the global battle against COVID-19 after the intravenously administered...
https://mfame.guru/74-of-remdesivir-treated-covid19-patients-gets-better-gilead-study-shows/